Autonomix Medical (AMIX) vs Trinity Biotech (TRIB)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Autonomix Medical is the larger company by market cap ($6.1 million vs $5.6 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AMIX | TRIB |
|---|---|---|
| Share price | $3.11 | $6.86 |
| Market cap | $6.10M | $5.57M |
| 1-day change | -0.64% | +13.49% |
| EPS (TTM) | $-39.67 | $-60.00 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $32.55 | $52.50 |
| 52-week low | $2.44 | $5.01 |
| Distance from 52-week high | -90.45% | -86.94% |
| Analyst consensus | none | — |
| Avg. price target upside | +1790.68% | — |
| Average volume | 4.50M | 21.66K |
| Shares outstanding | 1.96M | 813.13K |
| Employees | — | 287 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Autonomix Medical
AMIX stock →Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders of nervous system. The company's technology platform includes a catheter-based system incorporating microchip-enabled sensing architecture designed to detect low-amplitude neural signals from within the vascular system.
Health Care · Medical/Dental Instruments
About Trinity Biotech
TRIB stock →Trinity Biotech plc, together with its subsidiaries, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas, Asia, Africa, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detects infectious diseases; sexually transmitted diseases, such as syphilis and herpes; SARS-CoV-2; and epstein barr, measles, mumps, toxoplasmosis, cytomegalovirus, rubella, varicella and other viral pathogens, as well as products for the in-vitro diagnostic measurement of haemoglobin A1c used in the monitoring and diagnosis of diabetes, and identifying those who are at a risk of developing diabetes.
Health Care · Biotechnology: In Vitro & In Vivo Diagnostic Substances · 287 employees
AMIX vs TRIB FAQ
Which is bigger, Autonomix Medical or Trinity Biotech?
Autonomix Medical (AMIX) is larger, with a market capitalization of $6.10M compared with $5.57M for Trinity Biotech (TRIB).
Are Autonomix Medical and Trinity Biotech in the same industry?
Both are in the Health Care sector, but in different industries: Medical/Dental Instruments for Autonomix Medical and Biotechnology: In Vitro & In Vivo Diagnostic Substances for Trinity Biotech.